Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

FDA Fast-Tracks Heart Failure Gene Therapy

A biotechnology company developing transfers of healthy genes to treat chronic diseases is receiving an accelerated review of its heart failure therapy from the U.S. Food and Drug Administration. . . . → Read More: FDA Fast-Tracks Heart Failure Gene Therapy

CAR T-Cells Shown Effective in Long-Term Studies

Results from two clinical studies of engineered immune system cells show patients continue to respond their treatments after 6 months or more. . . . → Read More: CAR T-Cells Shown Effective in Long-Term Studies

PTSD Drug Trial Begins, Gets Fast-Track Status

An experimental drug that aims to keep nerve cells flexible is beginning an early-stage clinical trial as a treatment for post-traumatic stress disorder, or PTSD. . . . → Read More: PTSD Drug Trial Begins, Gets Fast-Track Status

Tobacco Plants Studied as Drug Bio-Factories

A university in Australia is joining a European research project to create new types of tobacco plants for producing pharmaceuticals. . . . → Read More: Tobacco Plants Studied as Drug Bio-Factories

Cell Programming Company Raises $49.5M in Early Funds

A start-up enterprise creating add-on treatments that program the effects of cell and gene therapies is raising $49.5 million in its first venture funding round. . . . → Read More: Cell Programming Company Raises $49.5M in Early Funds

Engineered Cells Identify Rare Epilepsy Drug Candidates

A process using high-speed screening of drug candidates with genetically engineered cells identified potential drugs to treat a rare form of childhood epilepsy. . . . → Read More: Engineered Cells Identify Rare Epilepsy Drug Candidates

Protein Made by Synthetic Bacteria with Expanded DNA

An academic-industry lab team produced a synthetic protein from an engineered bacteria, with DNA modified to expand its number of chemical coding components. . . . → Read More: Protein Made by Synthetic Bacteria with Expanded DNA

Large-Scale Genome Editing Technology in Development

Two biotechnology companies are creating an automated process for delivering large, complex genetic cargoes into cells for genome editing. . . . → Read More: Large-Scale Genome Editing Technology in Development

Genome Editing Enhances CAR T-Cells to Fight Cancer

A process using genome editing is shown to bolster cancer-fighting properties of T-cells from the immune system already modified to attack cancer cells. . . . → Read More: Genome Editing Enhances CAR T-Cells to Fight Cancer

Biotech, Cancer Center Partner on T-Cell Research

A developer of cancer diagnostics and treatments is collaborating with Moffitt Cancer Center to advance therapies for ovarian cancer with T-cells from the immune system. . . . → Read More: Biotech, Cancer Center Partner on T-Cell Research